US Patent Issued to Mesoblast International Sarl on Nov. 18 for "Use of mesenchymal lineage precursor cells or stem cells (MLPSCs) for delivery of oligonucleotides in the treatment of cancer" (American, Australian Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,547, issued on Nov. 18, was assigned to Mesoblast International Sarl (Meyrin, Sweden).

"Use of mesenchymal lineage precursor cells or stem cells (MLPSCs) for delivery of oligonucleotides in the treatment of cancer" was invented by Peter Brink (New York), Ira Cohen (New York), Richard Lin (New York), Sergey Doronin (New York), Irina Potapova (New York), Virginijus Valiunas (New York), Dan Devine (New York), Anthony Sandrasagra (New York), Nick Loizos (New York) and Silviu Itescu (Melbourne, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to cellular compositions that are modified to introduce a nucleic acid or ...